Journal articles on the topic 'Amyloid beta-protein Pathophysiology'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Amyloid beta-protein Pathophysiology.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Ma, Chen, Fenfang Hong, and Shulong Yang. "Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions." Molecules 27, no. 4 (February 11, 2022): 1210. http://dx.doi.org/10.3390/molecules27041210.
Full textAlasmari, Fawaz, Musaad A. Alshammari, Abdullah F. Alasmari, Wael A. Alanazi, and Khalid Alhazzani. "Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism." BioMed Research International 2018 (October 25, 2018): 1–8. http://dx.doi.org/10.1155/2018/3087475.
Full textGatti, Laura, Francesca Tinelli, Emma Scelzo, Francesco Arioli, Giuseppe Di Fede, Laura Obici, Leonardo Pantoni, et al. "Understanding the Pathophysiology of Cerebral Amyloid Angiopathy." International Journal of Molecular Sciences 21, no. 10 (May 13, 2020): 3435. http://dx.doi.org/10.3390/ijms21103435.
Full textCarbone, Manuel Glauco, Giovanni Pagni, Claudia Tagliarini, Donatella Marazziti, and Nunzio Pomara. "Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review." Life 11, no. 8 (July 26, 2021): 750. http://dx.doi.org/10.3390/life11080750.
Full textLAGUNES, TERESA, MARISOL HERRERA-RIVERO, MARÍA ELENA HERNÁNDEZ-AGUILAR, and GONZALO E. ARANDA-ABREU. "Abeta(1-42) induces abnormal alternative splicing of tau exons 2/3 in NGF-induced PC12 cells." Anais da Academia Brasileira de Ciências 86, no. 4 (December 2014): 1927–34. http://dx.doi.org/10.1590/0001-3765201420130333.
Full textKoike, Haruki, Yohei Iguchi, Kentaro Sahashi, and Masahisa Katsuno. "Significance of Oligomeric and Fibrillar Species in Amyloidosis: Insights into Pathophysiology and Treatment." Molecules 26, no. 16 (August 22, 2021): 5091. http://dx.doi.org/10.3390/molecules26165091.
Full textHultman, Karin, Sidney Strickland, and Erin H. Norris. "The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients." Journal of Cerebral Blood Flow & Metabolism 33, no. 8 (May 8, 2013): 1251–58. http://dx.doi.org/10.1038/jcbfm.2013.76.
Full textBesli, Nail, and Guven Yenmis. "Assessment of the Interaction of Aggregatin Protein with Amyloid-Beta (Aβ) at the Molecular Level via In Silico Analysis." Acta Chimica Slovenica 67, no. 4 (December 15, 2020): 1262–72. http://dx.doi.org/10.17344/acsi.2020.6175.
Full textKatsinelos, Taxiarchis, Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, and Jannis Kountouras. "Molecular Links Between Alzheimer's Disease and Gastrointestinal Microbiota: Emphasis on Helicobacter pylori Infection Involvement." Current Molecular Medicine 20, no. 1 (December 13, 2019): 3–12. http://dx.doi.org/10.2174/1566524019666190917125917.
Full textKulas, Joshua A., Kendra L. Puig, and Colin K. Combs. "Amyloid precursor protein in pancreatic islets." Journal of Endocrinology 235, no. 1 (October 2017): 49–67. http://dx.doi.org/10.1530/joe-17-0122.
Full textVidyanti, Amelia Nur, Jia-Yu Hsieh, Kun-Ju Lin, Yao-Ching Fang, Ismail Setyopranoto, and Chaur-Jong Hu. "Role of HMGB1 in an Animal Model of Vascular Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion." International Journal of Molecular Sciences 21, no. 6 (March 21, 2020): 2176. http://dx.doi.org/10.3390/ijms21062176.
Full textPal, Swadesh, and Roderick Melnik. "Coupled Neural–Glial Dynamics and the Role of Astrocytes in Alzheimer’s Disease." Mathematical and Computational Applications 27, no. 3 (April 21, 2022): 33. http://dx.doi.org/10.3390/mca27030033.
Full textModarresi, Farzaneh, Mohammad Ali Faghihi, Nikunj S. Patel, Barbara G. Sahagan, Claes Wahlestedt, and Miguel A. Lopez-Toledano. "Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis." International Journal of Alzheimer's Disease 2011 (2011): 1–11. http://dx.doi.org/10.4061/2011/929042.
Full textMatei, Nathanael, Sophie Leahy, Norman P. Blair, James Burford, Mansour Rahimi, and Mahnaz Shahidi. "Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer’s Disease." Cells 11, no. 15 (August 4, 2022): 2413. http://dx.doi.org/10.3390/cells11152413.
Full textMaarouf, Chera L., Tyler A. Kokjohn, Charisse M. Whiteside, MiMi P. Macias, Walter M. Kalback, Marwan N. Sabbagh, Thomas G. Beach, Robert Vassar, and Alex E. Roher. "Molecular Differences and Similarities between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis." Biochemistry Insights 6 (January 2013): BCI.S13025. http://dx.doi.org/10.4137/bci.s13025.
Full textNamme, Jannatun Nayem, Asim Kumar Bepari, and Hirohide Takebayashi. "Cofilin Signaling in the CNS Physiology and Neurodegeneration." International Journal of Molecular Sciences 22, no. 19 (October 3, 2021): 10727. http://dx.doi.org/10.3390/ijms221910727.
Full textKim, Dong Kyu, Dohyun Han, Joonho Park, Hyunjung Choi, Jong-Chan Park, Moon-Yong Cha, Jongmin Woo, et al. "Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer’s disease." Experimental & Molecular Medicine 51, no. 11 (November 2019): 1–17. http://dx.doi.org/10.1038/s12276-019-0326-z.
Full textDas, Rajib, Abdur Rauf, Saima Akhter, Mohammad Nazmul Islam, Talha Bin Emran, Saikat Mitra, Ishaq N. Khan, and Mohammad S. Mubarak. "Role of Withaferin A and Its Derivatives in the Management of Alzheimer’s Disease: Recent Trends and Future Perspectives." Molecules 26, no. 12 (June 17, 2021): 3696. http://dx.doi.org/10.3390/molecules26123696.
Full textAngelova, Hristina Tz, Daniela M. Pechlivanova, Boycho V. Landzhov, and Elena B. Dzhambazova. "The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease." Journal of Biomedical and Clinical Research 13, no. 1 (September 1, 2020): 8–18. http://dx.doi.org/10.2478/jbcr-2020-0002.
Full textScremin, Elena, Mario Agostini, Alessandro Leparulo, Tullio Pozzan, Elisa Greotti, and Cristina Fasolato. "ORAI2 Down-Regulation Potentiates SOCE and Decreases Aβ42 Accumulation in Human Neuroglioma Cells." International Journal of Molecular Sciences 21, no. 15 (July 25, 2020): 5288. http://dx.doi.org/10.3390/ijms21155288.
Full textVolmar, Claude-Henry, Hasib Salah-Uddin, Karolina J. Janczura, Paul Halley, Guerline Lambert, Andrew Wodrich, Sivan Manoah, et al. "M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory." Proceedings of the National Academy of Sciences 114, no. 43 (October 9, 2017): E9135—E9144. http://dx.doi.org/10.1073/pnas.1707544114.
Full textKim, Min Woo, Kyonghwan Choe, Jun Sung Park, Hyeon Jin Lee, Min Hwa Kang, Riaz Ahmad, and Myeong Ok Kim. "Pharmacological Inhibition of Spleen Tyrosine Kinase Suppressed Neuroinflammation and Cognitive Dysfunction in LPS-Induced Neurodegeneration Model." Cells 11, no. 11 (May 28, 2022): 1777. http://dx.doi.org/10.3390/cells11111777.
Full textRomaus-Sanjurjo, Daniel, Uxía Regueiro, Maite López-López, Laura Vázquez-Vázquez, Alberto Ouro, Isabel Lema, and Tomás Sobrino. "Alzheimer’s Disease Seen through the Eye: Ocular Alterations and Neurodegeneration." International Journal of Molecular Sciences 23, no. 5 (February 24, 2022): 2486. http://dx.doi.org/10.3390/ijms23052486.
Full textMontanari, Serena, Marco Allarà, Laura Scalvini, Magdalena Kostrzewa, Federica Belluti, Silvia Gobbi, Marina Naldi, et al. "New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators." Molecules 26, no. 11 (May 28, 2021): 3254. http://dx.doi.org/10.3390/molecules26113254.
Full textLampinen, Riikka, Mohammad Feroze Fazaludeen, Simone Avesani, Tiit Örd, Elina Penttilä, Juha-Matti Lehtola, Toni Saari, et al. "Single-Cell RNA-Seq Analysis of Olfactory Mucosal Cells of Alzheimer’s Disease Patients." Cells 11, no. 4 (February 15, 2022): 676. http://dx.doi.org/10.3390/cells11040676.
Full textde la Torre, Jack C. "Cardiovascular Risk Factors Promote Brain Hypoperfusion Leading to Cognitive Decline and Dementia." Cardiovascular Psychiatry and Neurology 2012 (December 3, 2012): 1–15. http://dx.doi.org/10.1155/2012/367516.
Full textKim, Young-Kook, Yoon Seok Jung, and Juhyun Song. "Transcriptome Profile in the Mouse Brain of Hepatic Encephalopathy and Alzheimer’s Disease." International Journal of Molecular Sciences 24, no. 1 (December 30, 2022): 675. http://dx.doi.org/10.3390/ijms24010675.
Full textGong, Mengting, Shoudong Ye, Wen-Xing Li, Jian Zhang, Yanjun Liu, Jie Zhu, Wenwen Lv, et al. "Regulatory function of praja ring finger ubiquitin ligase 2 mediated by the P2rx3/P2rx7 axis in mouse hippocampal neuronal cells." American Journal of Physiology-Cell Physiology 318, no. 6 (June 1, 2020): C1123—C1135. http://dx.doi.org/10.1152/ajpcell.00070.2019.
Full textHaque, Syed S. "Biomarkers in the diagnosis of neurodegenerative diseases." RUDN Journal of Medicine 26, no. 4 (December 23, 2022): 431–40. http://dx.doi.org/10.22363/2313-0245-2022-26-4-431-440.
Full textYoung, Malaney C., Nagamani Vunnam, Robyn T. Rebbeck, Samantha L. Yuen, David D. Thomas, and Jonathan N. Sachs. "Indirubin Inhibits TRAIL-Induced Activation of Death Receptor 5 in Jurkat Cells." Natural Product Communications 18, no. 1 (January 2023): 1934578X2211445. http://dx.doi.org/10.1177/1934578x221144580.
Full textPotenza, Maria Assunta, Luca Sgarra, Vanessa Desantis, Carmela Nacci, and Monica Montagnani. "Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?" Antioxidants 10, no. 8 (August 6, 2021): 1257. http://dx.doi.org/10.3390/antiox10081257.
Full textOstrovska, S. S., V. F. Shatorna, and E. O. Liholetov. "Intracellular ways of development of Alzheimer's disease against the background of herpes viral infections (literature review)." Medicni perspektivi (Medical perspectives) 26, no. 1 (March 26, 2021): 40–46. http://dx.doi.org/10.26641/2307-0404.2021.1.227729.
Full textVojdani, Aristo, and Elroy Vojdani. "Amyloid-Beta 1-42 Cross-Reactive Antibody Prevalent in Human Sera May Contribute to Intraneuronal Deposition of A-Beta-P-42." International Journal of Alzheimer's Disease 2018 (June 21, 2018): 1–12. http://dx.doi.org/10.1155/2018/1672568.
Full textO'Connor, Antoinette, Josef Pannee, Teresa Poole, Charles Arber, Erik Portelius, Imogen J. Swift, Amanda J. Heslegrave, et al. "Plasma amyloid-β ratios in autosomal dominant Alzheimer’s disease: the influence of genotype." Brain, April 23, 2021. http://dx.doi.org/10.1093/brain/awab166.
Full textSpotorno, Nicola, Chloé Najac, Erik Stomrud, Niklas Mattsson-Carlgren, Sebastian Palmqvist, Danielle van Westen, Itamar Ronen, and Oskar Hansson. "Astrocytic function is associated with both amyloid-β and tau pathology in non-demented APOE ε4 carriers." Brain Communications, May 22, 2022. http://dx.doi.org/10.1093/braincomms/fcac135.
Full textMorris, J. C. "EDITORIAL: IS NOW THE TIME FOR COMBINATION THERAPIES FOR ALZHEIMER DISEASE?" Journal Of Prevention of Alzheimer's Disease, 2019, 1–2. http://dx.doi.org/10.14283/jpad.2019.15.
Full textJennings, Matthew J., Denisa Hathazi, Chi D. L. Nguyen, Benjamin Munro, Ute Münchberg, Robert Ahrends, Annette Schenck, et al. "Intracellular Lipid Accumulation and Mitochondrial Dysfunction Accompanies Endoplasmic Reticulum Stress Caused by Loss of the Co-chaperone DNAJC3." Frontiers in Cell and Developmental Biology 9 (October 6, 2021). http://dx.doi.org/10.3389/fcell.2021.710247.
Full textLee, Ellen E., Charisse Winston-Gray, James W. Barlow, Robert A. Rissman, and Dilip V. Jeste. "Plasma Levels of Neuron- and Astrocyte-Derived Exosomal Amyloid Beta1-42, Amyloid Beta1-40, and Phosphorylated Tau Levels in Schizophrenia Patients and Non-psychiatric Comparison Subjects: Relationships With Cognitive Functioning and Psychopathology." Frontiers in Psychiatry 11 (March 2, 2021). http://dx.doi.org/10.3389/fpsyt.2020.532624.
Full textYao, Weiwei, Huihui Yang, and Jinfei Yang. "Small-molecule drugs development for Alzheimer's disease." Frontiers in Aging Neuroscience 14 (November 1, 2022). http://dx.doi.org/10.3389/fnagi.2022.1019412.
Full textRemnestål, Julia, Sofia Bergström, Jennie Olofsson, Evelina Sjöstedt, Mathias Uhlén, Kaj Blennow, Henrik Zetterberg, et al. "Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds." Alzheimer's Research & Therapy 13, no. 1 (March 2, 2021). http://dx.doi.org/10.1186/s13195-021-00789-5.
Full textIbanez, Laura, Jorge A. Bahena, Chengran Yang, Umber Dube, Fabiana H. G. Farias, John P. Budde, Kristy Bergmann, et al. "Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease." Acta Neuropathologica Communications 8, no. 1 (November 19, 2020). http://dx.doi.org/10.1186/s40478-020-01072-8.
Full textArtola Arita, V. A., B. T. Santeman, I. E. Sama, M. Kloosterman, I. Van Gelder, P. Van Der Meer, C. C. Lang, D. J. Van Veldhuisen, A. A. Voors, and M. Rienstra. "P566Activated amyloid-beta pathways in patients with atrial fibrillation and heart failure, a pathway analysis in BIOSTAT." EP Europace 22, Supplement_1 (June 1, 2020). http://dx.doi.org/10.1093/europace/euaa162.235.
Full textFlores, Joseph, Anastasia Noël, Bénédicte Foveau, Olivier Beauchet, and Andréa C. LeBlanc. "Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging." Nature Communications 11, no. 1 (September 11, 2020). http://dx.doi.org/10.1038/s41467-020-18405-9.
Full textTomaszewski, S., S. Gauthier, A. Wimo, and P. Rosa-Neto. "COMBINATION THERAPY OF ANTI-TAU AND ANTI-AMYLOID DRUGS FOR DISEASE MODIFICATION IN EARLY-STAGE ALZHEIMER’S DISEASE: SOCIO-ECONOMIC CONSIDERATIONS MODELED ON TREATMENTS FOR TUBERCULOSIS, HIV/AIDS AND BREAST CANCER." Journal of Prevention of Alzheimer's Disease, 2015, 1–9. http://dx.doi.org/10.14283/jpad.2015.85.
Full textTobieson, Lovisa, Henrik Zetterberg, Kaj Blennow, and Niklas Marklund. "Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage." Scientific Reports 11, no. 1 (August 20, 2021). http://dx.doi.org/10.1038/s41598-021-96364-x.
Full textCao, Lei, Yanyan Kong, Bin Ji, Yutong Ren, Yihui Guan, and Ruiqing Ni. "Positron Emission Tomography in Animal Models of Tauopathies." Frontiers in Aging Neuroscience 13 (January 10, 2022). http://dx.doi.org/10.3389/fnagi.2021.761913.
Full textSingh, Aayushi, and Asha Jha. "Cholinesterase Inhibitors Used for the Management of Alzheimer’s Disease: A Review." Journal of Pharmaceutical Research International, December 19, 2021, 121–28. http://dx.doi.org/10.9734/jpri/2021/v33i60a34463.
Full textFonteh, Alfred N., Abby J. Chiang, Xianghong Arakaki, Sarah P. Edminster, and Michael G. Harrington. "Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer’s Biomarkers Precedes Lipolysis in the Dementia Stage." Frontiers in Neuroscience 14 (December 16, 2020). http://dx.doi.org/10.3389/fnins.2020.611393.
Full textFonteh, Alfred N., Abby J. Chiang, Xianghong Arakaki, Sarah P. Edminster, and Michael G. Harrington. "Accumulation of Cerebrospinal Fluid Glycerophospholipids and Sphingolipids in Cognitively Healthy Participants With Alzheimer’s Biomarkers Precedes Lipolysis in the Dementia Stage." Frontiers in Neuroscience 14 (December 16, 2020). http://dx.doi.org/10.3389/fnins.2020.611393.
Full textHe, Zhijun, Xiaoqian Li, Shuangxue Han, Bingyu Ren, Xia Hu, Nan Li, Xiubo Du, Jiazuan Ni, Xiaogai Yang, and Qiong Liu. "Bis(ethylmaltolato)oxidovanadium (IV) attenuates amyloid-beta-mediated neuroinflammation by inhibiting NF-κB signaling pathway via a PPARγ-dependent mechanism." Metallomics 13, no. 7 (June 14, 2021). http://dx.doi.org/10.1093/mtomcs/mfab036.
Full text